Y Combinator placing a bet on a new generation of biotech start-ups

Y CombinatorY Combinator, the well-known Silicon Valley accelerator, is betting that biotech start-ups that use the latest computer science technologies such as machine learning will grow much more quickly than their counterparts and, as a result, should be funded more like tech start-ups. Read more about the team’s thinking here.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to tballard@pyapc.com. Include the name and contact information (phone and email) for follow-up.